Company news
Veradermics, Incorporated (NYSE:MANE) news
Veradermics, Incorporated news releases on 6ix. Latest, Sep 3, 2026: Veradermics to Present at Upcoming September Investor Conferences
Press releases & updates
Veradermics to Present at Upcoming September Investor Conferences
September 3, 2026
Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
August 11, 2026
Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302’ in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy
July 17, 2026
Veradermics’ Oral VDPHL01 Delivers Positive Study ‘207’ Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study ‘306’ Readout
July 15, 2026
Veradermics to Hold Conference Call to Discuss Study ‘207’ Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss
July 14, 2026
Veradermics to Present at Upcoming June Investor Conferences
May 28, 2026
Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 at the 2026 World Congress for Hair Research
May 27, 2026
Veradermics Announces Two Poster Presentations on VDPHL01 at the 2026 Music City SCALE Symposium
May 14, 2026
Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
May 12, 2026
Veradermics Announces Pricing of Upsized Public Offering and Private Placement
April 29, 2026
Veradermics Announces Launch of Public Offering
April 27, 2026
Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial in Male Pattern Hair Loss
April 27, 2026
Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
April 26, 2026
Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates
March 30, 2026
Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting
March 18, 2026
Veradermics to Participate in Upcoming March Investor Conferences
March 3, 2026
Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss
February 9, 2026
Veradermics Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
February 5, 2026
Veradermics Announces Pricing of Upsized Initial Public Offering
February 3, 2026